Depletion of Plasma Factor XIII Prevents Disseminated Intravascular Coagulation-induced Organ Damage
暂无分享,去创建一个
[1] T. Iba,et al. [Disseminated intravascular coagulation]. , 2003, Nihon rinsho. Japanese journal of clinical medicine.
[2] M. Caligiuri,et al. Cutting Edge: IL-15 Costimulates the Generalized Shwartzman Reaction and Innate Immune IFN-γ Production In Vivo1 , 2000, The Journal of Immunology.
[3] C. Vinson,et al. Fibrin fragment induction of plasminogen activator inhibitor transcription is mediated by activator protein-1 through a highly conserved element. , 1999, Blood.
[4] M. Levi,et al. The Pathophysiology of Disseminated Intravascular Coagulation , 1999, Thrombosis and Haemostasis.
[5] N. Koide,et al. Expression of Fas and Fas Ligand on Mouse Renal Tubular Epithelial Cells in the Generalized Shwartzman Reaction and Its Relationship to Apoptosis , 1999, Infection and Immunity.
[6] G. Darmstadt. Acute Infectious Purpura Fulminans: Pathogenesis and Medical Management , 1998, Pediatric dermatology.
[7] G. Senaldi,et al. Mortality and platelet depletion occur independently of fibrinogen consumption in murine models of tumour necrosis factor-mediated systemic inflammatory responses. , 1998, Cytokine.
[8] S. I. Chung,et al. Factors That Control Extravascular Fibrinolysis , 1996, Seminars in thrombosis and hemostasis.
[9] T. van der Poll,et al. Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades. , 1995, Clinical science.
[10] S. I. Chung,et al. Regulation of extravascular fibrinolysis by factor XIII , 1991 .
[11] H. Saito,et al. FDP D-dimer induces the secretion of interleukin-1, urokinase-type plasminogen activator, and plasminogen activator inhibitor-2 in a human promonocytic leukemia cell line. , 1991, Blood.
[12] M. Cardinali,et al. Interaction of fibrinogen with murine melanoma cells: covalent association with cell membranes and protection against recognition by lymphokine-activated killer cells. , 1990, Cancer research.
[13] J. Parrillo,et al. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. , 1989, The New England journal of medicine.
[14] S. Karpatkin,et al. Crossed immunoelectrophoresis of human platelet membranes. Effect of charge on association and dissociation of the glycoprotein GPIIb-GPIIIa membrane complex. , 1986, The Journal of biological chemistry.
[15] D. Crutchley,et al. Endotoxin induction of an inhibitor of plasminogen activator in bovine pulmonary artery endothelial cells. , 1986, The Journal of biological chemistry.
[16] J. Paramo,et al. Postoperative Changes in the Plasmatic Levels of Tissue-Type Plasminogen Activator and Its Fast-Acting Inhibitor - Relationship to Deep Vein Thrombosis and Influence of Prophylaxis , 1985, Thrombosis and Haemostasis.
[17] A. Siegelaub,et al. The leukocyte count as a predictor of myocardial infarction. , 1974, The New England journal of medicine.
[18] W. Hunter,et al. The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. , 1973, The Biochemical journal.
[19] F. Duckert. DOCUMENTATION OF THE PLASMA FACTOR XIII DEFICIENCY IN MAN , 1972, Annals of the New York Academy of Sciences.
[20] D. Deutsch,et al. Plasminogen: Purification from Human Plasma by Affinity Chromatography , 1970, Science.
[21] P. Lalezari,et al. A Rapid, Simple, Sensitive Method for Measuring Fibrinolytic Split Products in Human Serum∗ , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[22] B S Bull,et al. Platelet counts with the Coulter counter. , 1965, American journal of clinical pathology.